Breaking
FDA officials approve first-of-a-kind pill called daraxonrasib to fight one of the deadliest types of cancer
Read full story on The Guardian →
United States — Associated Press
FDA officials approve first-of-a-kind pill called daraxonrasib to fight one of the deadliest types of cancer
The US Food and Drug Administration (FDA) approved a groundbreaking new drug for the most common form of pancreatic cancer, offering US patients a more effective treatment against one of the deadliest types of the disease.
FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, that blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases. It’s an approach that has eluded drugmakers for decades.
The US Food and Drug Administration (FDA) approved a groundbreaking new drug for the most common form of pancreatic cancer, offering US patients a more effective treatment against one of the deadliest types of the disease.
This report is published with credit to The Guardian. The wire sent a summary; open the original for any extra context. Read on The Guardian →
Source: The Guardian · Associated Press. Published 26 Aug 2026, 04:48 pm.
Most relevant
The deal has been reached during a California federal court trial over claims brought by US states.
Read on BBC News →
